Obesity Care

What Obesity Care does

Obesity Care is a private, multidisciplinary medical practice based in Buenos Aires, Argentina, specializing in the surgical and non-surgical treatment of obesity, overweight, and type II diabetes. The practice operates from two physical locations — Sede Recoleta (Paraguay 2342, CABA) and Sede Canning (Mariano Castex 1078, Provincia de Buenos Aires) — and serves individual patients through a direct-to-consumer model, with appointment booking handled via dedicated WhatsApp numbers at each site and patient acquisition supported by Facebook and Instagram presence.

The clinical offering spans the full obesity care continuum: bariatric surgery (vertical gastrectomy/sleeve and gastric bypass), metabolic surgery for uncontrolled type II diabetes, revision bariatric surgery for failed prior procedures, and post-bariatric reparative (body contouring) surgery. Non-surgical options include the Allurion Elipse ingestible gastric balloon program — a partner-supplied offering that integrates a connected bioimpedance scale, Health Tracker watch, and the Allurion App for remote weight monitoring — as well as medical weight-loss treatment using injectable anti-obesity medications (Liraglutida, Semaglutida). All surgical procedures are performed using minimally invasive laparoscopic techniques.

The practice is physician-led, with Dr. Ariel Ferraro as Chief of Bariatric Surgery, supported by bariatric surgeons Dr. María Clotilde Gancedo and Dr. Martín Lerner, and a multidisciplinary team of three nutritionists, two psychologists, an endocrinologist (Dra. Yamila Morcarbel), and a plastic surgeon (Dr. Gonzalo Rogelio Lamas). The team holds accreditation from SACO (Sociedad Argentina de Cirugía de la Obesidad). Obesity Care generates revenue through fee-for-service payments for consultations and procedures, with no disclosed payer mix, procedure volume, or pricing. The firm is privately held, has no disclosed funding rounds, no parent company, and no subsidiaries, and operates exclusively within Argentina.

Name

Obesity Care

Legal name

Obesity Care

Website

https://obesitycare.com.ar

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Obesity Care is a private multidisciplinary medical practice in Buenos Aires, Argentina, offering surgical and non-surgical treatment of obesity, overweight, and type II diabetes through bariatric, metabolic, revision, and reparative procedures plus the Allurion balloon program, serving individual patients directly at two locations.

Ownership category

akta.pro rank

Product category

Bariatric Surgery Services

NAICS

Offices of Physicians (6211), Diet and Weight Reducing Centers (812191)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Obesity Medicine & Weight Management (HLAKADAL)

akta.pro secondary industry

Diabetes (General) (HLAKADAA)

Keywords

• Bariatric surgery services
• Metabolic surgery
• Obesity treatment
• Weight management programs
• Type II diabetes surgery

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Surgical Consultations and Procedures: Fee-for-service healthcare practice providing bariatric surgery, metabolic surgery, revision surgery, reparative surgery, and medical treatments. Revenue generated through direct patient payments for consultations and surgical procedures.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Obesity Care is a Buenos Aires-based multidisciplinary medical practice that provides surgical and non-surgical treatment for morbid obesity, overweight, and Type II diabetes. Surgical offerings include bariatric surgery (Vertical Gastrectomy / Gastric Bypass), metabolic surgery, revision bariatric surgery, and post-bariatric reconstructive surgery. Non-surgical offerings include the Allurion Elipse ingestible gastric balloon program with digital monitoring tools and medical weight loss treatment using injectable anti-obesity medications (Liraglutide, Semaglutide). All services are delivered by an in-house multidisciplinary team (surgeons, nutritionists, psychologists, endocrinologist) at two Buenos Aires locations.

Product overview

Obesity Care is a medical practice specializing in surgical and non-surgical treatment of obesity and overweight. The core offering consists of bariatric and metabolic surgeries (Gastrectomía Vertical, By-pass Gástrico, Cirugía Metabólica, Cirugía de Revisión) as the primary interventions, complemented by the Balón Gástrico Ingerible Elipse (Allurion Program) as a non-surgical alternative, and Tratamiento con Medicación for medical management. Post-weight-loss reconstructive surgery (Cirugía Reparadora Postbariátrica) addresses excess skin following significant weight reduction. All services are delivered through a multidisciplinary team approach at two locations in Buenos Aires.

Differentiator

Problem solved

Functional benefit

Brands

• Programa Allurion: Healthy lifestyle program featuring the Elipse ingestible gastric balloon with digital tools for weight loss monitoring.

Products and services

• Bariatric Surgery (Cirugía Bariátrica) Surgical treatment for morbidly obese patients (BMI greater than 40, or BMI greater than 35 with associated comorbidities such as Type II diabetes, arterial hypertension, ischemic heart disease, or hepatic steatosis) using restrictive and/or malabsorptive techniques to achieve weight loss and resolve associated diseases; delivered laparoscopically by the SACO-accredited team.
• Vertical Gastrectomy / Sleeve Gastrectomy (Gastrectomía Vertical) Restrictive weight-loss surgery that creates a narrow gastric tube of approximately 80–150cc by resecting about 70% of the stomach, limiting food intake per meal; performed laparoscopically.
• Gastric Bypass (By-pass Gástrico) Mixed-mechanism bariatric surgery (restrictive plus malabsorptive) creating a 30–50cc gastric pouch connected directly to the small intestine, bypassing the stomach, duodenum, and approximately 1.5 meters of small intestine; performed laparoscopically and used as the primary technique for metabolic surgery.
• Metabolic Surgery for Type II Diabetes (Cirugía Metabólica) Application of bariatric surgical techniques — primarily gastric bypass — to patients with Type II diabetes who cannot achieve optimal blood sugar levels with medical treatment alone, to achieve glycemic control, with cited over 85% cure or marked improvement and significant cardiovascular and blood-fat risk reduction.
• Revision Bariatric Surgery (Cirugía de Revisión Bariátrica) Corrective laparoscopic surgery for patients with prior bariatric procedures who require revision due to weight regain, complications, or insufficient weight loss.
• Post-Bariatric Reconstructive / Repair Surgery (Cirugía Reparadora Postbariátrica) Plastic and reconstructive surgery performed by Dr. Gonzalo Rogelio Lamas to address aesthetic defects, hygienic issues, and functional problems caused by excess skin and soft-tissue laxity after significant post-bariatric weight loss.
• Allurion Elipse Ingestible Gastric Balloon Program (Balón Gástrico Ingerible Elipse) Non-surgical weight-loss program using an ingestible, self-digesting gastric balloon that fills the stomach to reduce hunger, combined with a lifestyle program and a digital health toolkit (connected bioimpedance scale, Health Tracker watch, Allurion mobile app) that enables remote weight monitoring and team communication.
• Medical Weight Loss Treatment (Tratamiento con Medicación) Non-surgical weight-loss treatment using injectable anti-obesity medications (Liraglutide, Semaglutide) that reduce appetite and increase satiety, combined with nutritional planning and multidisciplinary monitoring, for overweight and obesity patients without surgical contraindications.

Quantifiable outcome

• Over 85% of patients achieve adequate weight loss and resolution or significant improvement of obesity-related diseases
• +3 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature2 records

Partnerships

One partnership is on record.

• Allurion (Programa Allurion)coreStrategic or Co-development PartnerIncorporated the Allurion Elipse Program, offering ingestible gastric balloon without surgery, endoscopy, or anesthesia. Includes comprehensive lifestyle program with digital health tools (connected scale, Health Tracker watch, mobile app) for weight monitoring and medical team communication.

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Others

• Ethicon (Johnson & Johnson MedTech): Major manufacturer of surgical stapling, energy, and suture devices used in laparoscopic bariatric procedures. Comparable as the enabling surgical-supply incumbent whose products Obesity Care depends on for its laparoscopic practice.

Broad incumbents

• Medtronic: Global medical device leader with a significant metabolic/bariatric surgery portfolio (including endoscopic and surgical tools). Comparable as a broader incumbent whose devices Obesity Care surgeons use and whose innovations shape the field.
• Novo Nordisk: Global pharmaceutical leader behind Wegovy (semaglutide) and Ozempic, the GLP-1 medications Obesity Care prescribes for medical weight management. A broader incumbent whose products are reshaping the obesity treatment landscape Obesity Care competes within.
• Apollo Endosurgery: US-listed maker of the Orbera intragastric balloon and other minimally invasive obesity interventions. Comparable as a broader, established player in the non-surgical and device-based obesity space in which Obesity Care operates.
• Eli Lilly: Global pharmaceutical company behind tirzepatide (Zepbound/Mounjaro) for obesity and T2D. Directly relevant as a dominant force in medical obesity treatment that competes with Obesity Care's medical therapy offering.

Emerging players

• Noom: Digital health platform offering app-based weight management with coaching and behavior change. Comparable as an emerging, lower-cost alternative targeting the same overweight/obese patient population that Obesity Care serves.
• WeightWatchers (WW): Established consumer weight management program that has expanded into GLP-1-supported care. Comparable as a non-clinical, mass-market weight management option competing for the same pre-bariatric patient population.

Regional players

• VLCC Healthcare: India-based chain of wellness and slimming centers offering non-surgical weight management. Comparable as a regional, multi-location weight management services operator; does not directly compete with Obesity Care in Argentina.

Direct peers

• Allurion Technologies: US-listed maker of the Elipse ingestible gastric balloon and digital health platform that Obesity Care distributes in Argentina. Directly comparable as a non-surgical, tech-enabled obesity intervention with similar patient outcomes focus.
• LIMARP International Center of Excellence for Obesity: Tijuana-based multidisciplinary bariatric and metabolic surgery center serving Latin American and medical-tourism patients. Comparable in offering bariatric, metabolic, revision, and post-bariatric care through a single integrated team.

Market position

Strengths5 records

Weaknesses2 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/cirugiaobesidadobesitycare
• Instagraminstagram.com/cirugiaobesidad
• LinkedInlinkedin.com/company/obesity-care-tratamiento-quirurgico-de-la-obesidad

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Obesity Care